乳腺癌的临床试验
总计53583个结果
-
Jose Pablo LeoneEli Lilly and Company; Translational Breast Cancer Research Consortium (TBCRC)招聘中
-
University of Colorado, DenverCancer League of Colorado撤销
-
BerGenBio ASAMerck Sharp & Dohme LLC终止
-
Eisai Co., Ltd.完全的
-
University of Utah主动,不招人0 期乳腺癌 | I期乳腺癌 | II期乳腺癌 | 浸润性乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 乳腺导管原位癌美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中浸润性乳腺癌 | I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | IIIA 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7美国
-
University of California, San FranciscoPuma Biotechnology, Inc.完全的HER2阳性乳腺癌 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 乳腺癌美国
-
William Carson主动,不招人解剖学 I 期乳腺癌 AJCC v8 | 解剖学 IA 期乳腺癌 AJCC v8 | 解剖学 IB 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 IA 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIA 期乳腺癌 AJCC v8 | 预后 IIB 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 乳腺导管原位癌 | 预防性乳房切除术美国
-
Washington University School of MedicineNational Institute for Biomedical Imaging and Bioengineering (NIBIB)完全的
-
Northwestern UniversityNational Cancer Institute (NCI)终止疼痛 | 周围神经病变 | IV 期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 化疗药物毒性 | 治疗相关毒性美国
-
SOLTI Breast Cancer Research Group招聘中
-
Melinda TelliPfizer; BioMarin Pharmaceutical完全的
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)主动,不招人三阴性乳腺癌 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 乳腺癌 | 双侧乳腺癌 | 单侧乳腺癌美国
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger HF; St. Olavs Hospital 和其他合作者完全的
-
McMaster University完全的
-
Gilead Sciences招聘中晚期实体瘤 | 转移性尿路上皮癌 | 转移性三阴性乳腺癌 | HR+/HER2- 转移性乳腺癌日本
-
University of ArizonaNational Cancer Institute (NCI)完全的
-
Alison Stopeck招聘中
-
Mayo ClinicNational Cancer Institute (NCI)完全的I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | IIIA 期乳腺癌 AJCC v7美国
-
Jonsson Comprehensive Cancer Center完全的癌症幸存者 | I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7 | IIIA 期乳腺癌 AJCC v7 | 0 期乳腺癌 AJCC v6 和 v7美国
-
Case Comprehensive Cancer Center撤销I期乳腺癌 | HER2阳性乳腺癌 | 男性乳腺癌 | II期乳腺癌 | 雌激素受体阴性乳腺癌 | 雌激素受体阳性乳腺癌 | 孕激素受体阴性乳腺癌 | 孕激素受体阳性乳腺癌 | HER2 阴性乳腺癌 | 乳腺导管原位癌 | 浸润性小叶乳腺癌 | 浸润性导管癌 | 伴有淋巴细胞浸润的髓样导管癌 | 粘液性导管乳腺癌 | 乳头状导管癌 | 管状导管癌美国
-
Eve Rodler尚未招聘乳腺癌 | 卵巢癌 | 乳腺肿瘤 | 乳腺癌 | 乳腺癌第四期 | 乳腺癌一期 | 乳腺癌二期 | 浸润性乳腺癌 | 癌症, 乳腺 | 乳腺癌三期 | 卵巢癌 | 乳腺恶性肿瘤 | 卵巢癌IIIC期 | 卵巢癌第四期 | 卵巢癌 III 期 | 乳癌 | 乳腺癌 IIB 期 | 侵袭性乳腺癌 | 卵巢肿瘤 | 卵巢癌 | 肿瘤,乳腺 | 乳腺癌 IIA 期 | 乳腺癌 IIIA 期 | 乳腺癌 IIIB 期 | 乳腺癌 IIIc 期 | 卵巢癌 IIIb 期 | 恶性乳腺肿瘤 | 卵巢癌第 3 期 | 乳腺癌 | 卵巢癌 1 期 | 卵巢癌二期 | 卵巢癌 IA 期 | IB期卵巢癌 | 卵巢癌 IC 期 | 卵巢癌 2 期 | 乳腺癌,IA 期 | 乳腺癌,IB 期美国
-
University of NebraskaNational Cancer Institute (NCI)主动,不招人HER2阳性乳腺癌 | I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7美国
-
Michael SimonNational Cancer Institute (NCI)完全的浸润性乳腺癌 | I 期乳腺癌 AJCC v7 | IA 期乳腺癌 AJCC v7 | IB 期乳腺癌 AJCC v7 | II 期乳腺癌 AJCC v6 和 v7 | IIA 期乳腺癌 AJCC v6 和 v7 | IIB 期乳腺癌 AJCC v6 和 v7美国
-
University of Wisconsin, Madison完全的癌症幸存者 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 健康主题 | I期结直肠癌 | IIIA期结直肠癌 | IIIB期结直肠癌 | IIIC期结直肠癌 | IIA期结直肠癌 | IIB期结直肠癌 | IIC期结直肠癌美国
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)主动,不招人II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 雌激素受体阳性乳腺癌 | HER2 阴性乳腺癌 | 浸润性小叶乳腺癌 | 浸润性导管癌美国, 波多黎各
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.招聘中
-
Ohio State University Comprehensive Cancer Center主动,不招人沮丧 | 复发性乳腺癌 | IIIA期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 癌症治疗的认知副作用美国
-
City of Hope Medical CenterNational Cancer Institute (NCI)终止IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 雌激素受体阳性乳腺癌 | 孕激素受体阳性乳腺癌 | 浸润性导管癌美国
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Washington University School of MedicineBiovica尚未招聘
-
Ahon Pharmaceutical Co., Ltd.招聘中
-
Ahon Pharmaceutical Co., Ltd.招聘中
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Onco Medical Consult GmbHEli Lilly and Company; Institut fuer Frauengesundheit未知晚期乳腺癌 | 转移性乳腺癌
-
AstraZeneca完全的晚期乳腺癌 | 转移性乳腺癌比利时, 火鸡, 加拿大, 波兰, 罗马尼亚, 匈牙利, 法国, 捷克语
-
Chang Gung Memorial HospitalEisai Co., Ltd.; Kaohsiung Breast Cancer Prevention and Education Society (KBCPES)未知
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的男性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 乳腺导管原位癌 | 小叶性乳腺癌原位癌美国
-
Hebei Medical University Fourth Hospital招聘中
-
Spanish Breast Cancer Research GroupAstraZeneca招聘中
-
Institut fuer FrauengesundheitSamsung Bioepis Co., Ltd.招聘中
-
Saint Luke's Health SystemNovartis Pharmaceuticals招聘中
-
Royal Marsden NHS Foundation TrustPfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave Roussy, Cancer... 和其他合作者招聘中HER2 阴性乳腺癌 | ER+乳腺癌英国, 法国
-
Wake Forest University Health SciencesAtrium Health Navicent主动,不招人